Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.
Clinical trial NCT00063128 · COMPLETED
Trial details
- NCT number
- NCT00063128
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.